NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN (NGAL) AS AN EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN HEPATIC PATIENTS

Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin are early predictors for acute kidney injury among patients admitted to the surgical ICU

Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) as Early Predictor of Acute Kidney Injury in Septic Patients

Neutrophil gelatinase-associated lipocalin as a biomarker for predicting acute kidney injury after coronary artery bypass grafting

Urinary Neutrophil Gelatinase-associated Lipocalin: As an Early Marker for Diabetic Nephropathy

Neutrophil gelatinase-associated lipocalin and oxidative stress markers based -scores to improve the diagnostic accuracy of chronic kidney diseases

Urinary Neutrophil Gelatinase Associated lipocalin (NGAL) as A Biomarker of Acute Kidney Injury in Patients with Liver Cirrhosis

Serum neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in patients with coronary artery disease

Predictability of at-admission Plasma Neutrophil Gelatinase– associated Lipocalin (NGAL) Level for Acute Kidney Injury in Patients admitted to Surgical Intensive Care Unit

The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients